Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

In vitro characterization of the interaction between HIV-1 Gag and human lysyl-tRNA synthetase.

Kovaleski BJ, Kennedy R, Hong MK, Datta SA, Kleiman L, Rein A, Musier-Forsyth K.

J Biol Chem. 2006 Jul 14;281(28):19449-56. Epub 2006 May 15.

2.

Critical role of helix 4 of HIV-1 capsid C-terminal domain in interactions with human lysyl-tRNA synthetase.

Kovaleski BJ, Kennedy R, Khorchid A, Kleiman L, Matsuo H, Musier-Forsyth K.

J Biol Chem. 2007 Nov 2;282(44):32274-9. Epub 2007 Aug 27.

3.

The interaction between HIV-1 Gag and human lysyl-tRNA synthetase during viral assembly.

Javanbakht H, Halwani R, Cen S, Saadatmand J, Musier-Forsyth K, Gottlinger H, Kleiman L.

J Biol Chem. 2003 Jul 25;278(30):27644-51. Epub 2003 May 19.

4.

Association of mitochondrial Lysyl-tRNA synthetase with HIV-1 GagPol involves catalytic domain of the synthetase and transframe and integrase domains of Pol.

Kobbi L, Octobre G, Dias J, Comisso M, Mirande M.

J Mol Biol. 2011 Jul 29;410(5):875-86. doi: 10.1016/j.jmb.2011.03.005.

PMID:
21763493
5.

Cellular distribution of Lysyl-tRNA synthetase and its interaction with Gag during human immunodeficiency virus type 1 assembly.

Halwani R, Cen S, Javanbakht H, Saadatmand J, Kim S, Shiba K, Kleiman L.

J Virol. 2004 Jul;78(14):7553-64.

6.

Interactions of reverse transcriptase sequences in Pol with Gag and LysRS in the HIV-1 tRNALys3 packaging/annealing complex.

Saadatmand J, Guo F, Cen S, Niu M, Kleiman L.

Virology. 2008 Oct 10;380(1):109-17. doi: 10.1016/j.virol.2008.07.015. Epub 2008 Aug 15.

7.

Dual role for motif 1 residues of human lysyl-tRNA synthetase in dimerization and packaging into HIV-1.

Dewan V, Wei M, Kleiman L, Musier-Forsyth K.

J Biol Chem. 2012 Dec 7;287(50):41955-62. doi: 10.1074/jbc.M112.421842. Epub 2012 Oct 24.

8.

Escherichia coli LysU is a potential surrogate for human lysyl tRNA synthetase in interactions with the C-terminal domain of HIV-1 capsid protein.

Boonyalai N, Pullen JR, Abdul Wahab MF, Wright M, Miller AD.

Org Biomol Chem. 2013 Jan 28;11(4):612-20. doi: 10.1039/c2ob26499d. Epub 2012 Dec 4.

PMID:
23208549
9.

Incorporation of lysyl-tRNA synthetase into human immunodeficiency virus type 1.

Cen S, Khorchid A, Javanbakht H, Gabor J, Stello T, Shiba K, Musier-Forsyth K, Kleiman L.

J Virol. 2001 Jun;75(11):5043-8.

10.

The tRNALys packaging complex in HIV-1.

Kleiman L, Cen S.

Int J Biochem Cell Biol. 2004 Sep;36(9):1776-86. Review.

PMID:
15183344
11.

The selective packaging and annealing of primer tRNALys3 in HIV-1.

Kleiman L, Halwani R, Javanbakht H.

Curr HIV Res. 2004 Apr;2(2):163-75. Review.

PMID:
15078180
12.
13.

Inhibition of cellular HIV-1 protease activity by lysyl-tRNA synthetase.

Guo F, Gabor J, Cen S, Hu K, Mouland AJ, Kleiman L.

J Biol Chem. 2005 Jul 15;280(28):26018-23. Epub 2005 May 10.

14.

Molecular mimicry of human tRNALys anti-codon domain by HIV-1 RNA genome facilitates tRNA primer annealing.

Jones CP, Saadatmand J, Kleiman L, Musier-Forsyth K.

RNA. 2013 Feb;19(2):219-29. doi: 10.1261/rna.036681.112. Epub 2012 Dec 21.

16.

In vitro and in silico binding study of the peptide derived from HIV-1 CA-CTD and LysRS as a potential HIV-1 blocking site.

Na Nakorn P, Treesuwan W, Choowongkomon K, Hannongbua S, Boonyalai N.

J Theor Biol. 2011 Feb 7;270(1):88-97. doi: 10.1016/j.jtbi.2010.11.010. Epub 2010 Nov 18.

PMID:
21093454
18.

Aspects of HIV-1 assembly that promote primer tRNA(Lys3) annealing to viral RNA.

Saadatmand J, Kleiman L.

Virus Res. 2012 Nov;169(2):340-8. doi: 10.1016/j.virusres.2012.06.001. Epub 2012 Jun 12. Review.

PMID:
22698876
20.

tRNA(Lys3): the primer tRNA for reverse transcription in HIV-1.

Kleiman L.

IUBMB Life. 2002 Feb;53(2):107-14. Review.

Supplemental Content

Support Center